Sehgal A, Safran J, Kratzer B, Gattinger P, Stieger R, Musiejovsky L
Vaccines (Basel). 2024; 12(4).
PMID: 38675759
PMC: 11053794.
DOI: 10.3390/vaccines12040377.
Jager W, Kicker E, Hardt M, Gawish R, Gattinger P, Bohmdorfer M
Molecules. 2023; 28(6).
PMID: 36985582
PMC: 10056577.
DOI: 10.3390/molecules28062612.
Gattinger P, Ohradanova-Repic A, Valenta R
Int J Mol Sci. 2023; 24(6).
PMID: 36982424
PMC: 10048970.
DOI: 10.3390/ijms24065352.
Byazrova M, Gattinger P, Astakhova E, Hofer G, Khaitov M, Filatov A
Int J Mol Sci. 2023; 24(6).
PMID: 36982183
PMC: 10049224.
DOI: 10.3390/ijms24065104.
Shkurnikov M, Nersisyan S, Averinskaya D, Chekova M, Polyakov F, Titov A
PeerJ. 2023; 11:e14707.
PMID: 36691482
PMC: 9864130.
DOI: 10.7717/peerj.14707.
Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency.
Goschl L, Mrak D, Grabmeier-Pfistershammer K, Stiasny K, Haslacher H, Schneider L
Front Immunol. 2022; 13:974987.
PMID: 36189225
PMC: 9515892.
DOI: 10.3389/fimmu.2022.974987.
Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants.
Gattinger P, Kratzer B, Tulaeva I, Niespodziana K, Ohradanova-Repic A, Gebetsberger L
Allergy. 2022; 77(8):2431-2445.
PMID: 35357709
PMC: 9111473.
DOI: 10.1111/all.15305.
Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma.
Kratzer B, Trapin D, Gattinger P, Oberhofer T, Sehgal A, Waidhofer-Sollner P
Vaccines (Basel). 2022; 10(3).
PMID: 35335006
PMC: 8949333.
DOI: 10.3390/vaccines10030374.
Characterization of the antibody response to SARS-CoV-2 in a mildly affected pediatric population.
Kopanja S, Gattinger P, Schmidthaler K, Sieber J, Niepodziana K, Schlederer T
Pediatr Allergy Immunol. 2022; 33(2):e13737.
PMID: 35212039
PMC: 9115525.
DOI: 10.1111/pai.13737.
Omicron: A SARS-CoV-2 variant of real concern.
Gattinger P, Tulaeva I, Borochova K, Kratzer B, Trapin D, Kropfmuller A
Allergy. 2022; 77(5):1616-1620.
PMID: 35188670
PMC: 9111213.
DOI: 10.1111/all.15264.
In Planta Production of the Receptor-Binding Domain From SARS-CoV-2 With Human Blood Group A Glycan Structures.
Konig-Beihammer J, Vavra U, Shin Y, Veit C, Grunwald-Gruber C, Gillitschka Y
Front Chem. 2022; 9:816544.
PMID: 35178379
PMC: 8846405.
DOI: 10.3389/fchem.2021.816544.
Development of Serological Assays and Seroprevalence Studies of the New Coronavirus 2019 (COVID-19): Reports from Saudi Arabia.
Alandijany T, Faizo A
Healthcare (Basel). 2021; 9(12).
PMID: 34946456
PMC: 8701666.
DOI: 10.3390/healthcare9121730.
An update comprehensive review on the status of COVID-19: vaccines, drugs, variants and neurological symptoms.
Ozkan Oktay E, Tuncay S, Kaman T, Karasakal O, Ozcan O, Soylamis T
Turk J Biol. 2021; 45(4):342-357.
PMID: 34803439
PMC: 8573837.
DOI: 10.3906/biy-2106-23.
Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020.
Siller A, Wachter G, Neururer S, Pfeifer B, Astl M, Borena W
Wien Klin Wochenschr. 2021; 133(23-24):1272-1280.
PMID: 34698961
PMC: 8546400.
DOI: 10.1007/s00508-021-01963-3.
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.
Gattinger P, Niespodziana K, Stiasny K, Sahanic S, Tulaeva I, Borochova K
Allergy. 2021; 77(1):230-242.
PMID: 34453317
PMC: 8653362.
DOI: 10.1111/all.15066.
Multiprofessional perinatal care in a pregnant patient with acute respiratory distress syndrome due to COVID-19.
Palmrich P, Roessler B, Wisgrill L, Kampf S, Gattinger P, Valenta R
BMC Pregnancy Childbirth. 2021; 21(1):587.
PMID: 34445988
PMC: 8390084.
DOI: 10.1186/s12884-021-04059-y.
Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.
Ahluwalia P, Vaibhav K, Ahluwalia M, Mondal A, Sahajpal N, Rojiani A
Front Immunol. 2021; 12:660019.
PMID: 34046033
PMC: 8144450.
DOI: 10.3389/fimmu.2021.660019.
Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation.
Khaitov M, Nikonova A, Shilovskiy I, Kozhikhova K, Kofiadi I, Vishnyakova L
Allergy. 2021; 76(9):2840-2854.
PMID: 33837568
PMC: 8251148.
DOI: 10.1111/all.14850.
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.
Peng H, Rhind S, Beckett A
JMIR Public Health Surveill. 2021; 7(4):e25500.
PMID: 33825689
PMC: 8245055.
DOI: 10.2196/25500.
Simultaneous CD8 T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs.
Ferrantelli F, Chiozzini C, Manfredi F, Giovannelli A, Leone P, Federico M
Vaccines (Basel). 2021; 9(3).
PMID: 33801926
PMC: 7999804.
DOI: 10.3390/vaccines9030240.
